These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 31236666

  • 1. Renal failure, respiratory distress, and an atypical purpuric rash in a full-term infant with omphalocele and hypospadias: Answers.
    Weiss AJ, Kronforst K.
    Pediatr Nephrol; 2019 Nov; 34(11):2339-2342. PubMed ID: 31236666
    [No Abstract] [Full Text] [Related]

  • 2. Renal failure, respiratory distress, and an atypical purpuric rash in a full-term infant with omphalocele and hypospadias: Questions.
    Weiss AJ, Kronforst K.
    Pediatr Nephrol; 2019 Nov; 34(11):2337-2338. PubMed ID: 31236665
    [No Abstract] [Full Text] [Related]

  • 3. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK, Kıhtır HS, Goknar N, Ersoy M, Akcay N, Sevketoglu E.
    Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
    [Abstract] [Full Text] [Related]

  • 4. Postpartum atypical hemolytic uremic syndrome with complement factor H mutation complicated by reversible cerebrovascular constriction syndrome successfully treated with eculizumab.
    Yamaguchi M, Hori M, Hiroshi N, Maruyama S.
    Thromb Res; 2017 Mar; 151():79-81. PubMed ID: 28167400
    [No Abstract] [Full Text] [Related]

  • 5. An Atypical Case of Atypical Hemolytic Uremic Syndrome.
    Francois T, Vande Walle J, Dhont E, Keenswijk W.
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):e111-e113. PubMed ID: 29750742
    [Abstract] [Full Text] [Related]

  • 6. Eculizumab for the treatment of atypical hemolytic uremic syndrome recurrence after kidney transplantation associated with complement factor H mutations: a case report with a 5-year follow-up.
    Okumi M, Omoto K, Unagami K, Ishida H, Tanabe K.
    Int Urol Nephrol; 2016 May; 48(5):817-8. PubMed ID: 26865178
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hemolytic uremic syndrome associated with Bordetella pertussis infection in a 2-month-old infant carrying a pathogenic variant in complement factor H.
    Madden I, Roumenina LT, Langlois-Meurinne H, Guichoux J, Llanas B, Frémeaux-Bacchi V, Harambat J, Godron-Dubrasquet A.
    Pediatr Nephrol; 2019 Mar; 34(3):533-537. PubMed ID: 30560448
    [Abstract] [Full Text] [Related]

  • 9. First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis.
    Szarvas N, Szilágyi Á, Tasic V, Nushi-Stavileci V, Sofijanova A, Gucev Z, Szabó M, Szabó A, Szeifert L, Reusz G, Rusai K, Arbeiter K, Müller T, Prohászka Z.
    Ital J Pediatr; 2014 Dec 11; 40():101. PubMed ID: 25496981
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thrombotic Microangiopathy with Complement Factor H Gene Mutations Unassociated with Atypical Hemolytic Uremic Syndrome.
    Oymak Y, Karapınar TH, Ay Y, Özcan E, Müminoğlu N, Aydın Köker S, Töret E, Berdeli A, Serdaroğlu E, Vergin C.
    Turk J Haematol; 2015 Sep 11; 32(3):275-6. PubMed ID: 26376595
    [No Abstract] [Full Text] [Related]

  • 12. Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
    Sharma S, Pradhan M, Meyers KE, Le Palma K, Laskin BL.
    Clin Nephrol; 2015 Sep 11; 84(3):181-5. PubMed ID: 25816809
    [Abstract] [Full Text] [Related]

  • 13. Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome Due to a Mutation in CFH.
    Habbig S, Bergmann C, Weber LT.
    Am J Kidney Dis; 2016 Mar 11; 67(3):532-3. PubMed ID: 26724167
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Atypical Hemolytic Uremic Syndrome Associated with Complement Factor H Mutation and IgA Nephropathy: A Case Report Successfully Treated with Eculizumab.
    Nakamura H, Anayama M, Makino M, Makino Y, Tamura K, Nagasawa M.
    Nephron; 2018 Mar 11; 138(4):324-327. PubMed ID: 29241200
    [Abstract] [Full Text] [Related]

  • 16. A complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab.
    Schalk G, Kirschfink M, Wehling C, Gastoldi S, Bergmann C, Hoppe B, Weber LT.
    Pediatr Nephrol; 2015 Jun 11; 30(6):1039-42. PubMed ID: 25752761
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
    Sevinc M, Basturk T, Sahutoglu T, Sakaci T, Koc Y, Ahbap E, Akgol C, Kara E, Brocklebank V, Goodship TH, Kavanagh D, Unsal A.
    J Med Case Rep; 2015 Apr 29; 9():92. PubMed ID: 25925370
    [Abstract] [Full Text] [Related]

  • 20. Eculizumab for atypical hemolytic uremic syndrome in pregnancy.
    Ardissino G, Wally Ossola M, Maria Baffero G, Rigotti A, Cugno M.
    Obstet Gynecol; 2013 Aug 29; 122(2 Pt 2):487-489. PubMed ID: 23884270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.